NAD+ Booster Safety Warning: May Shield Cancer Cells from Chemotherapy
Key Questions
What does the new preclinical study say about NAD+ boosters?
The study in Cancer Letters warns that NMN, NR, and NAM may help pancreatic cancer cells survive chemotherapy. This challenges existing safety assumptions in the longevity community.
Which NAD+ boosters are mentioned in the safety warning?
The warning covers popular boosters including NMN, NR, and NAM. These are widely used supplements in anti-aging contexts.
Why is this finding important for supplement users?
It highlights urgent gaps in clinical evidence and risks for anyone using these supplements, especially those undergoing or considering cancer treatment.
A new preclinical study in Cancer Letters warns that popular NAD+ boosters (NMN, NR, NAM) may help pancreatic cancer cells survive chemotherapy. This directly challenges safety assumptions in the longevity community and highlights urgent gaps in clinical evidence. A must-know for anyone using these supplements, especially those undergoing or considering cancer treatment.